88624847
Sep 20, 2019
Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of fibrosis, cirrhosis, liver disease, kidney disease, dermatological conditions and diseases, autoimmune diseases, inflammatory diseases, Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis (NASH), and Capsular contracture; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of fibrosis, cirrhosis, liver disease, kidney disease, dermatological conditions and diseases, autoimmune diseases, inflammatory diseases, Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis (NASH), and Capsular contracture; none of the foregoing for or related to the treatment of male erectile dysfunction
Pharmaceuticals